Cathy Lynn Vitez, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1057 Pysell Rd, Mc Henry, MD 21541 Phone: 443-478-0230 |
News Archive
Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.
Preliminary research has found that children with autism are more likely to have impaired mitochondrial function (structures within cells responsible for energy production) and mitochondrial DNA abnormalities than typically developing children, according to a study in the December 1 issue of JAMA.
Since its arrival in Haiti two years ago, "cholera has sickened more than 600,000 people and killed more than 7,500," and "[t]his year the epidemic is on track to be among the world's worst again, with nearly 77,000 cases and 550 deaths, according to the Haitian Ministry of Health," Ralph Ternier and Cate Oswald of Zanmi Lasante/Partners in Health in Haiti write in the Huffington Post's "Impact" blog.
Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program) to fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Alpha 1 Antitrypsin Deficiency (AAT), a genetic disease known to result in serious lung and/or liver disease.
Men with prostate cancer, particularly those receiving hormone therapy, may face an increased risk of blood clots or 'thromboembolism', scientists at King's College London have found.
› Verified 8 days ago